Display options
Cite
Chakraborty S, Pujani M, Haque SE. Combinational effect of resveratrol and atorvastatin on isoproterenol-induced cardiac hypertrophy in rats. J Pharm Bioallied Sci. 2015;7(3):233-8doi: 10.4103/0975-7406.160037.
Chakraborty, S., Pujani, M., & Haque, S. E. (2015). Combinational effect of resveratrol and atorvastatin on isoproterenol-induced cardiac hypertrophy in rats. Journal of pharmacy & bioallied sciences, 7(3), 233-8. https://doi.org/10.4103/0975-7406.160037
Chakraborty, Songjukta, et al. "Combinational effect of resveratrol and atorvastatin on isoproterenol-induced cardiac hypertrophy in rats." Journal of pharmacy & bioallied sciences vol. 7,3 (2015): 233-8. doi: https://doi.org/10.4103/0975-7406.160037
Chakraborty S, Pujani M, Haque SE. Combinational effect of resveratrol and atorvastatin on isoproterenol-induced cardiac hypertrophy in rats. J Pharm Bioallied Sci. 2015 Jul-Sep;7(3):233-8. doi: 10.4103/0975-7406.160037. PMID: 26229360; PMCID: PMC4517328.
Copy Download .nbib Format: NLM
Share it on

J Pharm Bioallied Sci. 2015 Jul-Sep;7(3):233-8. doi: 10.4103/0975-7406.160037.

Combinational effect of resveratrol and atorvastatin on isoproterenol-induced cardiac hypertrophy in rats.

Journal of pharmacy & bioallied sciences

Songjukta Chakraborty, Mukta Pujani, Syed Ehtaishamul Haque

Affiliations

  1. Department of Pharmacology, Faculty of Pharmacy, Hamdard Institute of Medical Sciences and Research, Jamia Hamdard, New Delhi, India.
  2. Department of Pathology, Hamdard Institute of Medical Sciences and Research, Jamia Hamdard, New Delhi, India.

PMID: 26229360 PMCID: PMC4517328 DOI: 10.4103/0975-7406.160037

Abstract

INTRODUCTION: Resveratrol is a natural polyphenol present mainly in grapes. It has been shown to offer strong cardio protection in animal models due to its ability to correct lipid peroxidation and maintain antioxidants level. Atorvastatin, a HMG-CoA reductase inhibitor, lowers cholesterol level and is commonly prescribed to heart patients. Our aim in this study was to see the combination effect of these two drugs against Isoproterenol-induced cardiac hypertrophy in rats.

MATERIALS AND METHODS: Wister Albino rats were treated with resveratrol (20 mg/kg/day, p.o), atorvastatin (20 mg/kg/day, p.o) and in combination (resveratrol [10 mg/kg/day, p.o] + atorvastatin [10 mg/kg/day, p.o]) for a period of 25 days and from 15(th) till 25(th) day Isoproterenol (5 mg/kg/day, s.c) was co-administered to rats to induce cardiac hypertrophy.

RESULTS: A significant increase in creatine kinase, lactate dehydrogenase, aspartate transaminase and lipid peroxidation with the significant decrease in reduced glutathione, superoxide dismutase and catalase were observed in Isoproterenol treated rats. Resveratrol, atorvastatin and their combination significantly reversed the effect. The histopathological studies and myocardial infarct size evaluation also confirmed the protection.

CONCLUSION: Comparing the data we came to this conclusion that atorvastatin although showed the protection along all the parameters, the extent of protection offered by resveratrol alone and in combination were more effective. Hence, it can be concluded that resveratrol, an herbal nutritional supplement, alone and in combination is better against cardiac hypertrophy.

Keywords: Atorvastatin; cardiac hypertrophy; isoproterenol; resveratrol

References

  1. Nature. 2003 Sep 11;425(6954):191-6 - PubMed
  2. Brain Res. 2002 Jun 28;942(1-2):23-30 - PubMed
  3. J Appl Physiol (1985). 2007 Jun;102(6):2104-11 - PubMed
  4. Med Sci (Paris). 2011 Apr;27(4):405-12 - PubMed
  5. Biochem Pharmacol. 2009 Apr 15;77(8):1303-15 - PubMed
  6. Anal Biochem. 1968 Oct 24;25(1):192-205 - PubMed
  7. Am J Pathol. 1963 Apr;42:379-405 - PubMed
  8. Eur J Biochem. 1974 Sep 16;47(3):469-74 - PubMed
  9. Arterioscler Thromb Vasc Biol. 2001 Dec;21(12 ):2059-64 - PubMed
  10. Circulation. 1999 Jul 13;100(2):178-84 - PubMed
  11. Nat Rev Mol Cell Biol. 2006 Aug;7(8):589-600 - PubMed
  12. Cancer Biol Ther. 2007 Dec;6(12):1833-6 - PubMed
  13. N Engl J Med. 1999 Oct 21;341(17):1276-83 - PubMed
  14. Circ Res. 2003 Jun 13;92(11):1171-5 - PubMed
  15. Anal Biochem. 1979 Jun;95(2):351-8 - PubMed
  16. N Engl J Med. 1990 Jan 11;322(2):100-10 - PubMed
  17. Pediatr Res. 2009 Aug;66(2):121-7 - PubMed
  18. Nature. 2006 Nov 16;444(7117):337-42 - PubMed
  19. Lancet. 1993 Jun 12;341(8859):1496-500 - PubMed
  20. J Nutr Biochem. 2013 Aug;24(8):1423-30 - PubMed
  21. Int J Biochem Cell Biol. 2007;39(1):44-84 - PubMed

Publication Types